NCT01670253

Brief Summary

The primary objective is to investigate whether intake of approximately 200 ml of sugary fluid 2 hours before the scheduled gastroscopy of the abdomen can reduce the discomfort of fasting period for patients without reducing the quality of the study. Current standard for fasting and fluid intake before gastroscopy is completely fasting 6 hours before the study. Studies in patients in general anesthesia has been found that it does not increase the risk of aspiration of stomach content during the operation by allowing the patient to drink up to 2 hours prior to anesthesia induction. There are no studies that have examined the quality gastroscopy using this fasting procedure. Some studies show that intake of sugary liquids do not have significant effect on gastric emptying. There are not deemed to be ethical problems with this study, as it seeks to show that a more lenient standard procedure in endoscopy is as safe as the established. The study is considered safe.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2014

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 22, 2012

Completed
1.4 years until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2014

Completed
Last Updated

August 29, 2019

Status Verified

August 1, 2019

Enrollment Period

11 months

First QC Date

August 14, 2012

Last Update Submit

August 27, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of uncomplicated examinations

    participants will be followed for the duration of hospital stay, an expected average of 1 hour

Secondary Outcomes (1)

  • Reduction of discomfort for the patients according to the survey.

    participants will be followed for the duration of hospital stay, an expected average of 1 hour

Study Arms (2)

Group 2

NO INTERVENTION

6 hours of total fast for all solid and liquid food / drinks

Group 1

EXPERIMENTAL

* 6 hour fast from all solid foods and milk beverages * 2-hour thirst period before examination (patient may be in the period from 6 to 2 hours before the study drink any kind of clear liquids, ie liquids containing no milk products) * Approximately 2 hours before the time of examination please drink a glass (about 2 cups) clear sugary liquid - eg lemonade, apple juice, iced tea, soda or the like.

Behavioral: Group 1

Interventions

Group 1BEHAVIORAL

* 6 hour fast from all solid foods and milk beverages * 2-hour thirst period before examination (patient may be in the period from 6 to 2 hours before the study drink any kind of clear liquids, ie liquids containing no milk products) * Approximately 2 hours before the time of examination please drink a glass (about 2 cups) clear sugary liquid - eg lemonade, apple juice, iced tea, soda or the like.

Group 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years
  • Sufficient knowledge of Danish to understand the written information
  • legally competent patients

You may not qualify if:

  • Patients with a history of pyloric stenosis (narrowing of the transition from stomach to the duodenum)
  • Incapacitated patients
  • Patients with daily vomiting.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Anton Bilenko, MD

    Odense University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 14, 2012

First Posted

August 22, 2012

Study Start

January 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 11, 2014

Last Updated

August 29, 2019

Record last verified: 2019-08